PACE: prognostic and predictive biomarkers in ER+/HER2- advanced breast cancer

(3:30)

Prognostic and predictive potential of CXCL11 in endocrine resistance in breast cancer

(50)

Dr. Crawford on Prognostic and Predictive Tests in Prostate Cancer

(1:42)

Prognostic and Predictive Markers in Colorectal Cancer

(6:2)

Prognostic and Predictive Markers in HCC

(8:16)

Poster Spotlight: Prognostic and Predictive Uses of Cell Free DNA

(1:45)

Prognostic and Therapeutic Insights into MIF, DDT, and CD74 in Melanoma | Oncotarget

(1:56)

Machine learning-based risk score for predicting atrial fibrillation in pts with CLL on BTKi therapy

(2:17)

Prognostic and Predictive Factors in Renal Cell Carcinoma

(8:16)

Prognostic and predictive biomarkers for long COVID

(2:26)

Prognostic and predictive biomarkers in CLL and their potential in guiding treatment decisions

(1:26)

Colon cancer: a new prognostic and predictive tool

(4:15)

Mutations in MDS - Prognostic and Therapeutic Implications

(56:23)

Genomic classifiers in breast cancer: Prognostic and predictive information: 2022 ESMO Florida

(2:37)

Prognostic and Predictive value of HER2 expression in Ductal Carcinoma in situ

(11:31)

ProsTIC24 - Edmond Kwan: Prognostic and Predictive Biomarkers for PSMA Theranostics - ctDNA

(11:5)

The prognostic and potentially therapeutic value of liquid biopsy in multiple myeloma

(1:5)

ASCO 2010: Prognostic and predictive markers in breast cancer

(8:45)

The use of machine learning to improve prognostic and diagnostic accuracy

(57:25)

XRCC1 as Potential Prognostic and Immunological Biomarker in LGG: Pan-Cancer Insights | Aging-US

(2:20)